Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

21.720
-0.620-2.78%
Volume:18.41M
Turnover:409.91M
Market Cap:55.13B
PE:25.55
High:23.100
Open:22.500
Low:21.500
Close:22.340
52wk High:36.800
52wk Low:9.642
Shares:2.54B
HK Float Shares:2.54B
Volume Ratio:0.84
T/O Rate:0.73%
Dividend:0.25
Dividend Rate:1.15%
EPS(LYR):0.850
ROE:13.95%
ROA:6.19%
PB:2.99
PE(LYR):25.55
PS:5.37

Loading ...

HK Stock Connect Shareholding Changes | Oct 28

Stock News
·
Oct 28, 2025

China Merchants Jinling International: Focus on the Progress of Authorized Drug Development, Recommend Buy on 3SBIO (01530) and Others

Stock News
·
Oct 27, 2025

Great Wall Pharmaceutical Industry Selected A Rises 15% in Q3, Increases Holdings in Innovent Bio and 3SBIO; Fund Manager Liang Furui: Current Innovative Drug Stocks Offer Great Value

Deep News
·
Oct 23, 2025

3SBio Inc. Announces New Equity Incentive Plan for Directors and Senior Management

Reuters
·
Oct 20, 2025

3SBio Inc. (Stock Code: 01530) Announces Equity Award Grant by Subsidiary Mandi Inc.

Bulletin Express
·
Oct 20, 2025

3SBIO Inc. (01530): Mandi Inc. Grants 640 Shares of Mandi as Incentives

Stock News
·
Oct 20, 2025

Investing in 3SBio (HKG:1530) three years ago would have delivered you a 417% gain

Simply Wall St.
·
Oct 19, 2025

HK Movers | Biomedical Stocks Surge With TransThera Sciences up 42%

Tiger Newspress
·
Oct 16, 2025

Is a Second Wave of Rally Starting? High-Volatility Hong Kong Stock Connect Innovative Drug ETF (520880) Soars 3.6%! DualityBio-B, 3SBIO, and Akeso Surge Collectively

Deep News
·
Oct 16, 2025

Hong Kong Stock Movement | 3SBIO (01530) Surges Over 8% After Submitting and Obtaining Approval for 601A Ocular Product

Stock News
·
Oct 16, 2025

Global Major Conference ESMO Enters Countdown, High-Elasticity Hong Kong Stock Connect Innovative Drug ETF (520880) Surges 2%! 3SBIO and ASCENTAGE-B Lead Strong Rally

Deep News
·
Oct 15, 2025

Shanxi Securities Company Limited Initiates Coverage on 3SBIO (01530) with "Buy-B" Rating: PD-1/VEGF Bispecific Antibody Shows Promise as Potential Cornerstone Cancer Therapy

Stock News
·
Oct 09, 2025

3SBio (SEHK:1530) Profit Margin Surges to 26%, Challenging Bearish Outlooks

Simply Wall St.
·
Oct 03, 2025

3SBio Inc. Reports 0.8% Decline in Revenue, Net Profit Up 24.6% for First Half of 2025

Reuters
·
Sep 30, 2025

China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others

Stock News
·
Sep 30, 2025

BOCOM International: Trump's Drug Tariffs Have Limited Impact on Chinese Pharmaceuticals, Recommends Focus on AKESO (09926) and Others

Stock News
·
Sep 29, 2025